BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 18, 2026
Home
»
Authors
» Holland Johnson
Holland Johnson
holland.johnson@clarivate.com
Articles
ARTICLES
Guidant CEO Dollens reveals plans to retire by the end of the year
June 1, 2004
By
Holland Johnson
NEJM
publishes data from two significant heart failure trials
June 1, 2004
By
Holland Johnson
GE Healthcare shines spotlight on its growing presence in cardiology
May 1, 2004
By
Holland Johnson
Eyeing next-generation device, Arrow defers U.S. trial of LionHeart
May 1, 2004
By
Holland Johnson
Stunning results seen from revascularization and other clinical data
May 1, 2004
By
Holland Johnson
Results of SCD-HeFT show significant cut in death risk with ICDs
April 1, 2004
By
Holland Johnson
Aerogen Closes First Tranche Of Planned $32.7M Investment
March 25, 2004
By
Holland Johnson
Aerogen Closes First Tranche Of Planned $32.7M Investment
March 25, 2004
By
Holland Johnson
Angiotech's Technology Approved In Boston Scientific's Coated Stent
March 8, 2004
By
Holland Johnson
Angiotech's Technology Approved In Boston Scientific's Coated Stent
March 8, 2004
By
Holland Johnson
View All Articles by Holland Johnson
